Park, AL, McDaid, D, Weiser, P, et al.
Examining the cost effectiveness of interventions to promote the physical health of people with mental health problems: A systematic review. BMC Public Health. 2013;13:787. PubMed PMID: 23988266. Pubmed Central PMCID: 3765875.
Nicod, E, Kanavos, P.
Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions. Health Policy. 2012;108:167–177.
Drummond, MF, Schwartz, JS, Jönsson, B, et al.
Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24:244–258.
van Velden, ME, Severens, JL, Novak, A. Economic evaluations of healthcare programmes and decision making. Pharmacoeconomics. 2005;23:1075–1082.
Oliver, K, Innvar, S, Lorenc, T, et al.
A systematic review of barriers to and facilitators of the use of evidence by policymakers. BMC Health Serv Res. 2014;14:2. PubMed PMID: 24383766. Pubmed Central PMCID: 3909454.
Macintyre, S, Chalmers, I, Horton, R, et al.
Using evidence to inform health policy: Case study. BMJ. 2001;322:222.
Health technology assessment and health policy-making in Europe: Current status, challenges and potential. Denmark: WHO Regional Office Europe; 2008.
Drummond, M. Economic evaluation in health care: Is it really useful or are we just kidding ourselves?
Aust Econ Rev. 2004;37:3–11.
Neumann, PJ. Why don't Americans use cost-effectiveness analysis. Am J Manag Care. 2004;10:308–312.
Neumann, PJ, Sullivan, SD.
Economic Evaluation in the US. Pharmacoeconomics. 2006;24:1163–1168.
Prosser, LA, Koplan, JP, Neumann, PJ, et al.
Barriers to using cost-effectiveness analysis in managed care decision making. Am J Manag Care. 2000;6:173–179.
Mühlbacher, AC, Kaczynski, A, Zweifel, P, et al.
Experimental measurement of preferences in health and healthcare using best-worst scaling: An overview. Health Econ Rev. 2015;6
Cheung, KL, Wijnen, BF, Hollin, IL, et al.
Using best–worst scaling to investigate preferences in health care. Pharmacoeconomics. 2016;34:1195–1209.
Finn, A, Louviere, JJ.
Determining the appropriate response to evidence of public concern: The case of food safety. J Public Policy Mark. 1992:12–25.
Train, KE. Discrete choice methods with simulation. Cambridge, UK: Cambridge University Press; 2009.
Flynn, TN, Louviere, JJ, Peters, TJ, et al.
Best–worst scaling: What it can do for health care research and how to do it. J Health Econ. 2007;26:171–189.
Marley, AA, Louviere, JJ. Some probabilistic models of best, worst, and best–worst choices. J Math Psychol. 2005;49:464–480.
Merlo, G, Page, K, Ratcliffe, J, et al.
Bridging the gap: Exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake. Appl Health Econ Health Policy. 2014;13:303–309.
van Gool, MK, Gallego, G, Haas, M, et al.
Economic evidence at the local level. Pharmacoeconomics. 2007;25:1055–1062.
Williams, I, Bryan, S. Understanding the limited impact of economic evaluation in health care resource allocation: A conceptual framework. Health Policy. 2007;80:135–143.
Huić, M, Nachtnebel, A, Zechmeister, I, et al.
Collaboration In health technology assessment (EU net HTA joint action, 2010–2012): Four case studies. Int J Technol Assess Health Care. 2013;29:323–330.
Drummond, M, Weatherly, H. Implementing the findings of health technology assessments. Int J Technol Assess Health Care. 2000;16:1–12.
Hivon, M, Lehoux, P, Denis, J-L, et al.
Use of health technology assessment in decision making: Coresponsibility of users and producers?
Int J Technol Assess Health Care. 2005;21:268–275.
Stakes, H, Rius, ME, Espinas, JA. EUR-ASSESS project subgroup report on dissemination and impact. Int J Technol Assess Health Care. 1997;13:220–286.
Brousselle, A, Lessard, C. Economic evaluation to inform health care decision-making: Promise, pitfalls and a proposal for an alternative path. Soc Sci Med. 2011;72:832–839.
Hoffmann, C, Stoykova, BA, Nixon, J, et al.
Do health‐care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. Value Health. 2002;5:71–78.
Understanding HB: An intuitive approach. Sequim, WA: Sawtooth Software Inc; 2000.
Orme, B. Hierarchical Bayes: Why all the attention?
Quirk's Mark Res Rev. 2000;14:16–63.
Ehlers, L, Jensen, MB. Attitudes and barriers toward mini-HTA in the Danish municipalities. Int J Technol Assess Health Care. 2012;28:271–277.
Oortwijn, W, Broos, P, Vondeling, H, et al.
Mapping of health technology assessment in selected countries. Int J Technol Assess Health Care. 2013;29:424–434.
Cheung, KL, Evers, SM, Hiligsmann, M, et al.
Understanding the stakeholders’ intention to use economic decision-support tools: A cross-sectional study with the Tobacco Return on Investment tool. Health Policy. 2016;120:46–54.
de Vries, H, Mudde, A, Leijs, I, et al.
The European Smoking prevention Framework Approach (EFSA): An example of integral prevention. Health Educ Res. 2003;18:611–626.
de Vries, H, Eggers, SM, Bolman, C. The role of action planning and plan enactment for smoking cessation. BMC Public Health. 2013;13: 393.
De Vries, H, Eggers, SM, Jinabhai, C, et al.
Adolescents’ beliefs about forced sex in KwaZulu-Natal, South Africa. Arch Sex Behav. 2014;43: 1–9.
Hoffmann, C, von der Schulenburg, J-MG.
The influence of economic evaluation studies on decision making.: A European survey. Health Policy. 2000;52:179–192.